TheFly.com
Open Search
keyboard_arrow_down
Type symbol to search
This symbol is non-existent:
List is empty.
Search
VTGN
VistaGen Therapeutics
$
()
VTGN
VistaGen Therapeutics reports FY22 EPS (25c), consensus (22c)
VTGN
6/23/2022 - 16:22pm
VistaGen's update on PALISADE-1 trial 'incrementally positive,' says Baird
VTGN
6/22/2022 - 11:54am
VistaGen Therapeutics appoints Reid Adler as Chief Legal Officer
VTGN
5/2/2022 - 08:19am
VistaGen, AffaMed complete regulatory preparations for PALISADE study
VTGN
4/12/2022 - 07:06am
VistaGen Therapeutics management to meet with Jefferies
VTGN
3/31/2022 - 10:54am
VistaGen Therapeutics management to meet with Jefferies
VTGN
3/30/2022 - 11:45am
VistaGen Therapeutics reports Q2 EPS (7c), consensus (6c)
VTGN
11/10/2021 - 17:13pm
VistaGen Therapeutics expands clinical development of PH94B
VTGN
10/14/2021 - 08:09am
VistaGen Therapeutics reports new preclinical mechanism of action data on PH94B
VTGN
10/5/2021 - 08:16am
VistaGen Therapeutics further advances PALISADE Phase 3 program for PH94B
VTGN
9/13/2021 - 06:05am
VistaGen Therapeutics reports Q1 EPS (4c), consensus (5c)
VTGN
8/12/2021 - 16:33pm
VistaGen Therapeutics appoints Maggie FitzPatrick to board of directors
VTGN
,
EXC
7/22/2021 - 08:26am
VistaGen Therapeutics appoints Mary Rotunno as board of directors
VTGN
7/7/2021 - 08:32am
VistaGen Therapeutics reports FY21 EPS (49c), consensus (22c)
VTGN
6/29/2021 - 16:23pm
dynamic_feed
Breaking News
search
Search
menu
Menu
TheFly.com TheFly.com
